| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jan 7, 2026 | Maze Therapeutics, Inc. (MAZE) | M | 20,744 | $10.42 | $216,152.48 | View Details Filing |
| Jan 7, 2026 | Maze Therapeutics, Inc. (MAZE) | M | 2,895 | $0.00 | $0.00 | View Details Filing |
| Jan 7, 2026 | Maze Therapeutics, Inc. (MAZE) | M | 3,281 | $0.00 | $0.00 | View Details Filing |
| Jan 7, 2026 | Maze Therapeutics, Inc. (MAZE) | S | 26,920 | $39.11 | $1,052,784.67 | View Details Filing |
| Jan 7, 2026 | Maze Therapeutics, Inc. (MAZE) | M | 2,895 | $10.42 | $30,165.90 | View Details Filing |
| Jan 7, 2026 | Maze Therapeutics, Inc. (MAZE) | M | 3,281 | $10.42 | $34,188.02 | View Details Filing |
| Jan 7, 2026 | Maze Therapeutics, Inc. (MAZE) | M | 20,744 | $0.00 | $0.00 | View Details Filing |
| Jan 6, 2026 | Maze Therapeutics, Inc. (MAZE) | M | 2,493 | $0.00 | $0.00 | View Details Filing |
| Jan 6, 2026 | Maze Therapeutics, Inc. (MAZE) | S | 2,493 | $38.62 | $96,269.69 | View Details Filing |
| Jan 6, 2026 | Maze Therapeutics, Inc. (MAZE) | M | 2,493 | $10.42 | $25,977.06 | View Details Filing |
| Jan 5, 2026 | Altimmune, Inc. (ALT) | P | 500 | $4.24 | $2,117.55 | View Details Filing |